A new drug that could slow the progression of Alzheimer’s disease has been approved as safe to use – but it has also been deemed as too costly to be prescribed on the NHS.
The Medicines and Healthcare products Regulatory Agency (MHRA) has on Thursday said Lecanemab is safe and effective, reports Sky News.